Medicine

Hibernation science took advantage of to handle weight problems and customize metabolic rate

.Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy recognizing t...

CAR- T and also mobile gene therapies are also expensive

.Nature Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care prod...

The WHO genomics course of help fair implementation of human genomics for worldwide health

.The magazine of the first draft of the individual genome sequence in 20011 was actually adhered to ...

A time-stratified, case\u00e2 $ \"crossover study of warmth visibility and also perinatal death coming from 16 health centers in sub-Saharan Africa

.One of 138,015 hospital-based singleton births in 4 sub-Saharan African nations, our company notice...

Advancing global antibiotic investigation, progression and also accessibility #.\n\nMurray, C. J. L. et al. International worry of microbial antimicrobial resistance in 2019: an organized analysis. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. Towards particular devotions as well as action in the action to antimicrobial protection. Worldwide Frontrunners Team on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Planet Health And Wellness Organization. WHO publishes listing of micro-organisms for which brand-new prescription antibiotics are actually urgently required. Globe Health Association https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Health Organization. WHO bacterial top priority virus listing, 2024: microbial virus of public health relevance to guide analysis, development and also tactics to prevent and also regulate antimicrobial protection. Planet Health and wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt way to Gram-negative entry. Bioorg. Medication. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic protection. Ups. J. Medication. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle.com Scholar\u00c2.\nPlanet Health Association. 2023 antibacterial agents in clinical as well as preclinical development: a review and also study. Planet Wellness Association https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Testimonial. May 19, 2016 \u00e2 $\" Taking on drug-resistant infections internationally: final report as well as suggestions. Testimonial on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Consortium. DRIVE-AB outcomes: documents as well as instruction. Drive abdominal https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et al. Breaking through the wall structure: a call for concerted action on prescription antibiotics experimentation. Boston Consulting Team https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Quick 51: Just how can the EU assistance sustainable development and access to effective antibiotics? policy options for existing and new medicines. International Observatory on Health And Wellness Equipments and Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Antibiotic usage as well as resistance\u00e2 $\" proving the evident. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Health Institution. 2021 Knowledgeable classification. That get access to, watch, reserve, category of prescription antibiotics for examination and also surveillance of utilization. Planet Health and wellness Association https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). International Center for Condition Avoidance as well as Control. Antimicrobial protection intendeds: how can our team reach them by 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Planet Health Association. Absence of advancement readied to undermine antibiotic functionality as well as health gains. Planet Wellness Institution https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. Exactly how antimicrobial resistance is connected to climate improvement: an introduction of pair of entwined international problems. Int. J. Environ. Res. Public Health 20, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial infections: we require emergency action and assets that focus on the weakest link. PLoS Biol. 20, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Wellness Company. Immunization coverage. Globe Health and wellness Organization https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Disease prevention and also command in low-resource environments: the necessity for the regional, the contextual and also the practical. Contaminate. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Difficulties of executing antimicrobial conservation tools in reduced to mid income nations (LMICs). Contaminate. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nAminov, R. A quick past of the antibiotic period: sessions learned as well as challenges for the future. Front. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et al. Patient gain access to in 14 high-income countries to brand new antibacterials permitted due to the US Food and Drug Administration, European Medicines Firm, Japanese Pharmaceuticals as well as Medical Equipment Company, or even Health Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Health And Wellness Organization. 2021 antibacterial brokers in scientific and also preclinical advancement: an outline and also study. Globe Health and wellness Organization https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Anti-biotics: the economics should assist the science. Attributes 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The state of technology in antibacterial rehabs. Biotechnology Advancement Association https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Evaluating clinician utilization of next-generation antibiotics versus resistant Gram-negative contaminations in united state health centers: a retrospective associate study. Ann. Intern. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The condition of advancement in anti-bacterial therapeutics. Medical Development Company https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A methodical customer review as well as essential examination of reward tactics for discovery and advancement of novel prescription antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle Scholar\u00c2.\nWellness Emergency Situation Readiness as well as Action Authorization. R &amp d of medical countermeasures. European Commission https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). European Payment. Pre-draft proposal for an European alliance under Horizon Europe One Health And Wellness Antimicrobial Protection. International Commission https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). International Anti-biotic Trial And Error Collaboration. Entasis Therapies as well as the Worldwide Antibiotic Investigation &amp Development Partnership to build a brand-new procedure for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of market- and non-industry-sponsored scientific tests. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health And Wellness Organization. Lot of medical test signs up through site, ailment, period of advancement, age and sex of test attendees (1999\u00e2 $ \"2022). World Health Company https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Global Antibiotic Trial And Error Alliance. NeoSept1: a research to calculate the position of existing and also brand new anti-biotics mixes to manage newborn babies that are in hospital along with intense sepsis. ISRCTN pc registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Firm of Canada. Government of Canada makes important assets to overcome antimicrobial resistance (AMR), Authorities of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). Worldwide Antibiotic Experimentation Partnership. Japan authorities backing sustains GARDP\u00e2 $ s attempts to respond to antibiotic resistance. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 Oct 2023). Novo Nordisk Base. Novo Nordisk Structure companions with CARB-X to fight drug-resistant diseases. novo nordisk structure https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). International Commission: European Wellness and Digital Manager Organization. Research study on bringing AMR medical countermeasures to the market place. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Determining the appropriate measurements of international pull motivations for antibacterial medicines. Health and wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimension a market entrance perks for the advancement of brand-new anti-biotics. Harvard Kennedy Institution https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Business motivations and antibiotic protection: an overview to the antibiotic vulnerability reward. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle Scholar\u00c2.\nBonnifield, R. &amp Towse, A. A determined USG advanced commitment for subscription-based getting of unique antimicrobials and also its assumed roi. Facility for Global Advancement https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 November 2022). Towse, A. &amp Silverman Bonnifield, R. G7 expenditures in brand new antibiotics would certainly settle \u00e2 $\" for every person. Workplace of Health and wellness Economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS steps up fight versus deadly diseases following successful world-first pilot. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). US Our lawmakers. S. 1355 \u00e2 $\" PASTEUR Act of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). European Percentage. Reform of the EU pharmaceutical legalisation. European Compensation https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et cetera. Repayment models to attack market breakdowns for antimicrobials: strategies taken in France, Germany, Sweden, the United Kingdom, as well as the USA. Wellness Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nInternational Alliance of Pharmaceutical Manufacturers as well as Organizations. From protection to durability: what could the potential antibiotic pipeline look like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). Worldwide AMR R&ampD Hub &amp Planet Health And Wellness Association. Incentivising the development of brand new anti-bacterial procedures: 2023 report card by the Global AMR R&ampD Hub as well as That. Global AMR R&ampD Hub https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Performer, A., Roberts, A. P. &amp Kirchhelle, C. Why is actually the UK registration design for anti-biotics considered successful? Lancet Microorganism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNon-paper \u00e2 $\" unfamiliar stimuli for the growth and keeping the marketplace of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, regional, and also nationwide causes of child death in 2000\u00e2 $ \"13, with estimates to educate post-2015 priorities: an improved organized study. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nQuadri, F. et cetera. Antibacterial medication lacks from 2001 to 2013: ramifications for medical practice. Clin. Contaminate. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nBenhabib, A. et cetera. The French reporting system for drug lacks: description as well as styles coming from 2012 to 2018: an empirical retrospective research study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et cetera. Evaluation of that antibiotic consumption and also accessibility targets in 76 nations, 2000\u00e2 $ \"15: an analysis of pharmaceutical purchases information. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Combating the counterfeits: handling shoddy and also falsified medications. Nat. Rev. Dis. Guides 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it acquiring easier to obtain antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nBlack Community for Laboratory Medicine. Policy concise as well as infographics on antimicrobial protection (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et cetera. National antibiotic consumption for individual make use of in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional research study. Trop. Medication. Contaminate. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nNamugambe, J. S. et al. National antimicrobial consumption: evaluation of core warehouses materials to in-patient care health and wellness locations from 2017 to 2019 in Uganda. Trop. Medication. Affect. Dis. 6, 83 (2021 ).\nGoogle.com Scholar\u00c2.\nRobertson, J. et cetera. Varieties in the usage of antimicrobial medications in the International region, 2014\u00e2 $ \"2018: lookings for and effects from ESAC-Net and also That Europe. Face. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nShukar, S. et cetera. Medication scarcity: causes, influence, and minimization tactics. Front end. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Patient access in 14 high-income countries to brand-new antibacterials authorized by the United States Fda, European Medicines Firm, Japanese Pharmaceuticals and also Medical Instruments Company, or Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPulcini, C. et cetera. Forgotten prescription antibiotics: a follow-up stock study in Europe, the United States, Canada as well as Australia. Int. J. Antimicrob. Brokers 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted health and wellness innovation for international wellness. Br. Med. J. 366, 15601 (2019 ).\nGoogle.com Scholar\u00c2.\nAMR Sector Partnership. The 2023 AMR Sector Partnership development poll: production as well as the atmosphere. amr Industry Collaboration https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Invasion, D. &amp Gaule, P. Can clinical products be developed on a non-profit basis? Checking out product advancement partnerships for neglected illness. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nSwaminathan, S. et al. Reboot biomedical R&ampD in the worldwide social enthusiasm. Attribute 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Health Condition Management as well as Avoidance. Africa CDC heads daring move to safeguard Africa\u00e2 $ s health and wellness future through creating a 50 billion buck health care market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Gore, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Discussing public-health intellectual property licensing contracts to improve access to wellness technologies: an insider\u00e2 $ s story. BMJ Glob. Health 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New service versions for r &amp d along with cost criteria are actually required to accomplish fair rates of medications. Br. Medication. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nCombating Antibiotic-Resistant Micro-organisms Biopharmaceutical Accelerator. Conservation and accessibility. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). International Antibiotic R &amp D Relationship. Shinogi, GARDP as well as CHAI announce landmark certificate as well as collaboration arrangements to manage bacterial infections by expanding access to cefiderocol in 135 nations. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Sector Alliance. Leaving the lab: tracking the decline in AMR R&ampD professionals. amr Sector Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Health And Wellness Ministers. G7 Health And Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (20 May 2022). G20. G20 call to action on antimicrobial resistance. G7G20 Documentations Database https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 Oct 2022). Worldwide Union on Growing Old &amp Contagious Conditions Society of United States. 2024 AMR readiness mark report card. Gauging government action on AMR policy. Global Coalition on Aging https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food Items as well as Agriculture Company of the United Nations, United Nations Setting Programme, Planet Wellness Company &amp. Globe Organisation for Animal Health And Wellness. International database for tracking antimicrobial resistance (AMR): nation self-assessment study (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Truck Katwyk, S. R. &amp Outterson K. Introduction: AMR belongs in th...

Integrating liver endpoints in medical tests of cardio and also renal health condition

.Attributes Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Poin...

FALSE:: ERROR: UNSUPPORTED ENCODING...

Artificial knowledge directed screening process for cardiomyopathies in an obstetric population: a pragmatic randomized clinical test

.Trial concept and oversightThe Screening process for PEripartum Cardiomyopathies along with Artific...

Sustained HIV remission after allogeneic hematopoietic stalk tissue transplantation along with wild-type CCR5 benefactor cells

.Attributes Medication, Published online: 02 September 2024 doi:10.1038/ s41591-024-03277-zHIV remis...

Senolytics target cellular senescence-- however can they slow down getting older?

.In the 1960s, United States anatomist Leonard Hayflick observed that replicative cells possess a mi...